Ad
Tuesday, 1 August 2017
Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar
NEW YORK (Reuters) - Daiichi Sankyo on Tuesday said it has agreed to pay up to $300 million to settle some 2,300 U.S. cases accusing the Japanese drugmaker of failing to warn that its blood pressure medication Benicar can cause gastrointestinal illness.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment